Elevated levels of PSA have been associated with prostatic adenocarcinoma and have been used as a risk factor in the clinic for both disease onset and severity, though the PSA test’s low specificity can lead to overdiagnosis and overtreatment [5,6]. Here, KLK3 is linked to prostate adenocarcinoma.